Growth Metrics

China Pharma Holdings (CPHI) Leases: 2018-2025

Historic Leases for China Pharma Holdings (CPHI) over the last 6 years, with Sep 2025 value amounting to $197,851.

  • China Pharma Holdings' Leases rose 235.73% to $197,851 in Q3 2025 from the same period last year, while for Sep 2025 it was $197,851, marking a year-over-year increase of 235.73%. This contributed to the annual value of $38,298 for FY2024, which is 67.16% down from last year.
  • As of Q3 2025, China Pharma Holdings' Leases stood at $197,851, which was up 931.76% from $19,176 recorded in Q1 2025.
  • In the past 5 years, China Pharma Holdings' Leases registered a high of $197,851 during Q3 2025, and its lowest value of $19,176 during Q1 2025.
  • Moreover, its 3-year median value for Leases was $87,132 (2024), whereas its average is $91,152.
  • Per our database at Business Quant, China Pharma Holdings' Leases crashed by 81.52% in 2023 and then soared by 390.25% in 2024.
  • Over the past 5 years, China Pharma Holdings' Leases (Quarterly) stood at $127,958 in 2021, then slumped by 69.49% to $39,046 in 2022, then soared by 198.65% to $116,610 in 2023, then plummeted by 67.16% to $38,298 in 2024, then surged by 235.73% to $197,851 in 2025.
  • Its last three reported values are $197,851 in Q3 2025, $19,176 for Q1 2025, and $38,298 during Q4 2024.